Monitoring of Circulating Tumor DNA and Indication of De-Escalation Adjuvant Targeted Therapy for EGFR-Mutated NSCLC After Complete Resection.
Dong S, Yan B, Liu SY, Gao X, Hong HZ, Li HJ, Gao W, Yan HH, Maggie Liu SY, Tu HY, Pan Y, Zhou Q, Yang XN, Xia XF, Yi X, Zhong WZ, Wu YL, Zhang JT.
Dong S, et al. Among authors: pan y.
JTO Clin Res Rep. 2024 Nov 2;6(1):100758. doi: 10.1016/j.jtocrr.2024.100758. eCollection 2025 Jan.
JTO Clin Res Rep. 2024.
PMID: 39758595
Free PMC article.